NCT05629364Phase 2Terminated

A Multi-Centre, Randomised, Controlled, Masked Phase 2 Study of the Safety and Efficacy of KIO-101 Ophthalmic Solution, Versus Vehicle Control in the Treatment of Dry Eye Disease in Patients With Autoimmune Disease

Study sponsor: Kiora Pharmaceuticals, Inc. · KPRX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2024-01-09Actual
Enrollment · participants4Actual
Source updated2024-01-10Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview